Trial Profile
A study of long-term efficacy and safety of calcipqotriol hydrate/betamethasone dipropionate ester fixed dose combination product in patients with psoriasis vulgaris
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 18 May 2017
Price :
$35
*
At a glance
- Drugs Betamethasone-dipropionate/calcipotriol (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 18 May 2017 New trial record